Sprouty genes are expressed in osteoblasts and inhibit fibroblast growth factor-mediated osteoblast responses

X Yang1, J B Webster, D Kovalenko

  • 1Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA.

Insights

Fibroblast Growth Factor 1 (FGF1) stimulates Spry2 expression in osteoblasts, acting as an early response. Spry2 then inhibits FGF1-driven osteoblast differentiation, potentially via Raf-1 interaction.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Fibroblast growth factors (FGFs) and their receptors (FGFRs) are critical regulators of skeletal development.
  • FGFR signaling pathways influence cell proliferation, differentiation, and migration.
  • Spry gene family members antagonize FGFR signaling, impacting various developmental processes.

Purpose of the Study:

  • To investigate the role of Spry2 in osteoblast differentiation.
  • To determine the response of Spry2 expression to FGF1 stimulation in MC3T3-E1 cells.
  • To elucidate the inhibitory mechanism of Spry2 on FGF1-induced osteoblast responses.

Main Methods:

  • Examined Spry2 expression in MC3T3-E1 cells following FGF1 stimulation.
  • Utilized pharmacological inhibitors of mitogen-activated protein kinase (MAPK) pathway.
  • Performed transient overexpression of Spry2 and analyzed downstream signaling (ERK phosphorylation, osteopontin promoter activity).
  • Investigated Spry2 interaction with Raf-1 using glutathione-S-transferase pulldown assays.
  • Assessed Spry2 expression relative to osteoblast differentiation markers in primary osteoblasts.

Main Results:

  • FGF1 stimulation induced Spry2 expression in MC3T3-E1 cells as an early response gene.
  • MAPK pathway inhibitors reduced FGF1-induced Spry2 mRNA expression.
  • Spry2 overexpression decreased FGF1-mediated ERK phosphorylation and osteopontin promoter activity.
  • Spry2 was shown to interact with Raf-1.
  • Spry2 expression preceded the onset of differentiation marker expression in primary osteoblasts.

Conclusions:

  • Spry2 is an early response gene to FGF1 in osteoblasts.
  • Spry2 acts as a feedback inhibitor of FGF1-induced osteoblast responses.
  • Spry2 may inhibit FGF1 signaling through interaction with Raf-1, modulating osteoblast differentiation.

Related Concept Videos

Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Gene Regulation During Sporulation01:17

Gene Regulation During Sporulation

Sporulation is a complex developmental process that allows certain Gram-positive bacteria, such as Bacillus subtilis and Clostridium species, to survive extreme environmental conditions. This process is tightly regulated by a series of signaling cascades and transcriptional controls, ensuring the formation of a highly resistant endospore.Sporulation is triggered by unfavorable conditions, such as nutrient depletion, and is governed by a phosphorelay system. One of the sensor kinases, such as...